Hepion Pharmaceuticals, Inc. /
Gravitas Life Sciences, LLC
Hepion Pharmaceuticals, Inc. completed its deal for Gravitas Life Sciences, LLC.
Source for the buyer and target: Hepion Pharmaceuticals, Inc.
For the buyer and target.
“On October 6, 2026, Hepion Pharmaceuticals, Inc. (the “Company”) entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Gravitas Life Sciences, LLC, a Delaware limited liability company (“GLS”), and Gravitas Collective Corp., a Delaware corporation and the sole member of GLS (the “Sole Member”), pursuant to which the Company agreed to acquire from the Sole Member all of the issued and outstanding membership interests (the “Purchase Securities”) of GLS (the “Transaction”).”
Published 9 Oct 2026
Open the sourceWhat happened
The deal for Gravitas Life Sciences, LLC has closed, with Hepion Pharmaceuticals, Inc. as the buyer, at a stated price of $2,000,000 in cash and (ii) 25,000,000 shares of the Company’s common stock. [01]
The filing from Hepion Pharmaceuticals, Inc. is dated Oct. 9, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Hepion Pharmaceuticals, Inc. completed its deal for Gravitas Life Sciences, LLC.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly